Stories related to Innovation

Liver cancer

HCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.

Future cures are in our genes

The next generation of pioneering medicines, led by gene therapy, is blazing a path towards truly personalised global healthcare, strengthened by partnering.

Roche in complement-mediated diseases

What happens when the complement system, a vital part of the immune system, is not properly regulated? Learn more about complement-mediated diseases.

Revolutionising clinical research through digital innovation

Can smartphone apps help us solve unanswered questions in rare diseases? Roche’s Scott Schobel discusses recent innovations in Huntington’s disease research.

The value of Diagnostics in managing COVID-19

Widespread, reliable testing can help the world chart a course back to normal life.

Managing influenza and COVID-19 during the influenza season

Examining the differences between COVID-19 and influenza and the role Roche has played in the pandemic, including perspectives from Barry Clinch.

Cancer genomic testing – Jamal Tamer’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient Jamal Tamer about the real-world impact it can have.

Cancer genomic testing – Debbie Rhea’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient Debbie Rhea about the real-world impact it can have.

Can wearable technology change the future of neuroscience research?

Scientists are finding new, innovative ways to collect clinical trial data in real-time that will allow regulators to make more accurate, informed decisions

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Organoids: turning science fiction to reality

The Roche Institute for Translational Bioengineering (ITB) is accelerating research into using organoids to predict the safety and efficacy of new molecules.

The Roche Institute for Translational Bioengineering

The Roche Institute for Translational Bioengineering in Basel advances the use of new human model technologies in discovery and early phase drug development.

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Pursuing cancer elimination one cancer type at a time

Curing or eliminating cancer for long seemed like a pipe dream. But that is starting to change. Eliminating cervical cancer is within reach.

For cancer patients, personalised care matters more than ever

Mobile blood draw programs bring comprehensive genetic profiling and personalised care to cancer patients – the hidden victims of the pandemic

3 factors to help decide on the appropriate SARS-CoV-2 test

The broad variety and availability of tests related to SARS-CoV-2 helps manage the Covid-19 pandemic. Choosing the appropriate test depends on three factors.

The next chapter of breast cancer treatment

George Gauthier reflects on the extraordinary 30-year journey Roche has travelled in breast cancer, and the hugely exciting potential destinations of the future.

Blood ties: in it together

Collaborating with the haematology community can help accelerate treatment advances for people affected by blood disorders, a complex area of medicine.

An evolution in strategies for cervical cancer prevention

Advanced screening and diagnostic tests are key to improving disease prevention strategies.

Cancer care can’t wait

Lung cancer in the era of COVID-19

How medicines are made: manufacturing and production

Manufacturing is a complicated and rigorous process that prioritises safely getting life-saving medicines to patients in need.

Behind the scenes at our experimental manufacturing site

Cells never sleep, so we test equipment and processes around the clock to make new medicines faster and safer.

Finding cancer’s fingerprint

How comprehensive genomic profiling – through tissue and liquid-based approaches – is driving truly personalised cancer care.

Getting closer to cancer research's holy grail

Combining clinical and genomic data to advance personalised healthcare.

Achieving the future of healthcare starts now

FutureProofing Healthcare drives decision-making based on data and evidence, and an understanding of what works for patients, professionals, and people.

It takes the power of partnership

With a shared dedication to bring innovative treatments to SMA patients, the SMA Foundation, PTC Therapeutics and Roche show the power of collaboration.

Explore the role of a specialist MS nurse

Learn how specialist MS nurse Anna Cunningham, helps people with MS manage their condition

Roche at ESMO 2020

Elena Bernedo Arzac, Head of Oncology, GPS at Roche Pharmaceuticals: Accelerating innovation with collaboration throughout the pandemic.

Efficiency meets Ecology

More efficient testing help reduce environmental footprint

Meet our Roche pRED scientists

Learn more about our scientists and how they are tackling many devastating diseases.

Finding hope in difficult times

Michelle’s diagnosis with NMOSD initially devastated her, but she refuses to let it prevent her from living her life. She shares her story here.

What it takes to be a great scientist

Roche scientist Hasani Ratni shares what he believes that to be an exceptional scientist, you have to break some rules and believe the impossible is possible.

James Sabry on the future of medicine

Roche’s Global Pharma Partnering leader talks about the nature of different diseases and future therapies

The future hinges on partnerships

Call it what you will – a near-death experience, a revelation, an awakening. But when you talk with Alain Bindels, you’ll find a man changed by COVID-19.

Building bridges

Learn how we are partnering with healthcare systems around the world to improve cancer care and lay the groundwork for personalised healthcare.

Environmental protection is part of our history

Severin Schwan about our long history in sustainability and the state of the human race.

Zero emissions or bust

Innovation and partnerships power Genentech e-bus programme

COVID-19: How antibody tests help to detect those already infected with SARS-CoV-2

SARS CoV-2 infections often go without symptoms. Antibody tests can identify individuals who have been exposed to the virus. Learn how this works.

Turning the tide of COVID-19

Widespread, reliable testing can help the world chart a course back to normal life.

COVID-19: How molecular testing detects SARS-CoV-2

Testing is the best way to be sure that someone is positive for the SARS-CoV-2 infection. Learn how testing using PCR works.

A global health crisis inspires unique partnerships

In the race to detect and treat COVID-19, biotech, government and academia are joining forces to battle a disease that knows no borders.

Researching the coronavirus in the search for solutions

Head of Infectious Diseases at Roche Pharma Early Research & Development, John Young shares his insights on the biology of covid-19 and outlook on future cures.

No rest in the hunt for novel antibiotics

Multi-drug resistance is on the rise. But tackling the global crisis of antimicrobial resistance requires joint efforts and unique innovation.

COVID-19: Containing and conquering a global health threat

Broad access to reliable coronavirus testing is essential to an outbreak containment strategy.

An iceberg of lost memories

Geoffrey Kerchner explains why Alzheimer’s is like an iceberg; most disease activity happens slowly below the surface, before you see the first symptoms.

Advancing personalised healthcare requires an ability to adapt

Tongtong Wang’s team develops ways to create and deliver tomorrow’s treatments.

Discussing multiple sclerosis through storytelling

Hear from Annarita and her family about how she used storytelling to explain the impact of the progressive nature of multiple sclerosis.

Roche Diagnostics product portfolio

Roche Diagnostics is transforming the way diseases can be prevented, diagnosed and monitored.

External innovation opens new doors for advancing science

Global Head of Pharma Partnering James Sabry is excited to embrace the potential of external innovation and innovative partners.

Partnering to drive innovation in cancer immunotherapy

We’re partnering with many different stakeholders to find the most effective way for the immune system to identify and kill cancer cells.

Democratising healthcare

Cross-sector collaborations are making healthcare more democratic, accessible and effective.

Our Roche Innovation Centers

Our organisation has more than 2,200 scientists at seven Roche Innovation Centers spanning each major continent

Autism Spectrum Disorder: A journey with unique challenges

Kathy Hyde hopes that telling her son’s story will help increase understanding of the challenges faced by individuals with autism spectrum disorder.

Will genomics revolutionise the future of medicine?

Joanne Hackett talks about genomics, healthcare, big data and people’s hesitation to share medical data.

Will quantum computers solve the problems of the future?

Martin Strahm talks about the idea, the potential and the limitations of quantum computers.

The future is patient-centric and data-driven

Tim M. Jaeger talks about the future of healthcare, the power of knowing and why human interaction will remain indispensable in the age of AI.

Our response to cancer always starts with the science

Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.

Taking a stand against cancer

All you need to know about the people and the important work at Roche Pharma Research and Early Development (pRED) Oncology as we discover the future in cancer care.

Open-sourcing health

Effective and purposeful collaborations will allow us to do much more together, to be much smarter together, than we can be alone.

Personalised healthcare and the complexity of data sharing

Mark Lee & Tim Jaeger discuss the shifting the paradigm of transparency and patient privacy when it comes to data

Seeing the unseen with artificial intelligence

AI could change the way ophthalmologists diagnose eye conditions like diabetic macular edema

The value of diagnostics in heart failure management

Heart failure affects millions of people and despite improvement in care, management remains challenging. Biomarkers can help patients at every stage of care.

Calculating the unimaginable

Quantum computers promise to offer computing power far beyond anything we can imagine.

Roche results for half-year 2019

When everyday counts, data makes a meaningful difference for patients

A conversation with Roland Beckmann, inventor of the DutaMab technology

Interview with Dutalys co-founder and inventor of the DutaMab technology platform, Roland Beckmann, on his invention and journey founding a biotech.

Scaling up cancer care

Personalised healthcare is becoming a reality across the continuum of cancer care, from the nanoscale to the national.

Our philanthropic journey

Over 100 years of partnerships to make a sustainable difference for communities in which we operate and beyond.

Tumour-agnostic treatments: A radical new approach to tackling cancer

Learn how tumour-agnostic approaches have the potential to change the way we diagnose, and treat, cancer in the future.

An introduction to personalised healthcare for the eye

Insights on how personalised healthcare can bring meaningful benefits to patients with retinal diseases

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

What is Personalised Healthcare?

Personalised healthcare is about providing the right treatment for the right patient. Fitting treatments to patients has always been the objective of medicine, of course. But only recent advances in science and technology have made this possible.

Elevating the patient voice in Huntington’s disease

How patient partnership is shaping the future of research and clinical development for Huntington’s disease.

Partnering to fulfil the promise of personalised healthcare

The promise of personalised healthcare is a simple one: finding the right treatment for every patient. Through strategic partnerships, Roche is committed to fulfilling that promise.

Will the future be feminine?

Betsy Leatherman talks about leadership characteristics that are said to be “female” and what this means for the future.

Hepatitis B - Aiming for cure of a killer

Hepatitis B is responsible for more than 800,000 deaths a year. Roche is working on a cure.

How decades of blood cancer research is paying off

We explore how a growing understanding of the biology of blood cancers is transforming the development and delivery of treatments for patients.

A boon for biotech

Our local partners are helping to shape the future of healthcare.

Roche at WCLC 2018

Understanding lung cancer, strand by strand

Beating lung cancer – one gene at a time

How gene targeting might transform the lives of patients with rare forms of lung cancer

Striking back at stroke risk

Why less is more in atrial fibrillation management

The patient as partner

Empowered patients are redefining the healthcare environment on their own terms.

The NT-proBNP Story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Partnering to improve cancer care in the Middle East

Peter Hug, Head of Roche Pharma EEMEA Region shares his perspective on partnering to solve cancer challenges in emerging markets.

Progress in haemophilia: a personal perspective

The haemophilia community is united and strong. Find out more about the haemophilia community and progress being made in the field from Brian O’Mahony, Chief Executive of the Irish Haemophilia Society.

Sustainability at Roche: Our impact

Engaging with stakeholders is crucial to create sustainable value. Stakeholder engagement enables us to jointly develop solutions.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

Highlights Annual Report 2017

Read the incredible stories behind the numbers.

Roche at J.P. Morgan Healthcare Conference

Collaborating to drive the future of personalised healthcare

Rising to the challenge

As multidrug resistant strains of bacteria are posing a growing threat to human health worldwide, our scientists are working hard on the next generation of antibiotics and diagnostic tests.

Integrated, connected laboratories: a new era in lab testing

A new era in lab testing is tackling today’s challenges and tomorrow’s needs in a rapidly shifting global health landscape.

Changing the perspective on lung cancer: a story of hope and survival

How does understanding each lung cancer’s unique footprint set you on the right path for a promising new future? Find out...

MS measurements explained

How we define the ways in which multiple sclerosis can be measured.

The realities of pursuing the cure for cancer

Cindy Perettie, our Global Head of Oncology Strategy, provides her personal perspective on the challenges of leading the cure for cancer.

Smart technology speeds up development of antibiotics

Roche and British biotechnology company Discuva are collaborating to develop new classes of antibiotics for the treatment of multidrug-resistant bacteria.

Fighting antimicrobial resistance with diagnostics

Antimicrobial resistance is a global and continuously raising global health challenge. Here’s what we are doing to address this problem.

Organs-on-a-Chip technology

Tiny labs made of plastic simulate the human body- the Organs-on-a-Chip technology shows new approaches to obtain human-relevant information on a potential drug.

Annual Report 2016 highlights

Creating value through partnerships

Partnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.

No woman needs to die from cervical cancer

Despite being highly preventable through screening,treatment and vaccination, cervical cancer remains one of the most common and deadly women’s cancer.

Spotlight on comprehensive genomic profiling

Comprehensive genomic profiling provides valuable information that can help determine the best possible treatment for each patient.

Annual Report 2015 highlights

A quick journey through Roche’s business year at a glance.

Excellence in science

pRED scientists pursue excellence. Patients are waiting, so by pushing boundaries pRED scientists make breakthroughs every day.